GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Current Deferred Revenue

G&E Healthcare Co (XKRX:299480) Current Deferred Revenue : ₩0.00 Mil (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

G&E Healthcare Co's current deferred revenue for the quarter that ended in . 20 was ₩0.00 Mil.

G&E Healthcare Co Current Deferred Revenue Historical Data

The historical data trend for G&E Healthcare Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Current Deferred Revenue Chart

G&E Healthcare Co Annual Data
Trend
Current Deferred Revenue

G&E Healthcare Co Semi-Annual Data
Current Deferred Revenue

G&E Healthcare Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines